CPT^® 81554, Under Multianalyte Assays with Algorithmic Analyses

The lab analyst performs the technical lab test on a transbronchial biopsy specimen for mRNA gene expression profiling for 190 genes and carries out an algorithmic analysis using patient data and the lab–test results to report a categorical result of positive or negative for a high probability of usual interstitial pneumonia (UIP).

CPT® 2021 adds 81554 to the section for Multianalyte Assays with Algorithmic Analyses (MAAAs) for mRNA gene expression profiling of 190 genes associated with pulmonary disease such as idiopathic pulmonary fibrosis (IPF) on a transbronchial biopsy specimen. As with all MAAAs, the code describes both the lab test and an algorithm that uses the test results and possibly other patient data to calculate a probability or risk score. In this case, the MAAA establishes that the specimen falls in the category of positive or negative for a high probability of usual interstitial pneumonia (UIP).

Effective date of this code: January 1, 2021.

For clinical responsibility, terminology, tips and additional info
start codify free trial.